WDB coco Co (TSE:7079) Net Margin %: 16.66% (As of Mar. 2026) — 15% Above Median


TSE:7079 WDB coco Co Ltd TSE:7079
78 GF Score
Price 円2,529.00
GF Value 円3,452.59
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is WDB coco Co Net Margin %?

WDB coco Co TSE:7079 -0.47% 78 Net Margin % is 16.66% as of Mar. 2026, which is 15% above its 10-year median of 14.52. GuruFocus rates TSE:7079 with a GF Score™ of 78/100 and a GF Value™ of 円3,452.59 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 668 Healthcare Providers & Services companies, WDB coco Co ranks better than 86.68% on this metric.

Net margin is calculated as Net Income divided by its Revenue. WDB coco Co's Net Income for the six months ended in Mar. 2026 was 円400 Mil. WDB coco Co's Revenue for the six months ended in Mar. 2026 was 円2,401 Mil. Therefore, WDB coco Co's net margin for the quarter that ended in Mar. 2026 was 16.66%.

The historical rank and industry rank for WDB coco Co's Net Margin % or its related term are showing as below:

TSE:7079' s Net Margin % Range Over the Past 10 Years
Min: 13.28   Med: 14.52   Max: 18.67
Current: 14.11


TSE:7079's Net Margin % is ranked better than
86.68% of 668 companies
in the Healthcare Providers & Services industry
Industry Median: 2.885 vs TSE:7079: 14.11

WDB coco Co  (TSE:7079) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


WDB coco Co Net Margin % Related Terms


WDB coco Co Net Margin % Historical Data

* Premium members only.

The historical data trend for WDB coco Co's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

WDB coco Co Net Margin % Chart

WDB coco Co Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Net Margin %
Get a 7-Day Free Trial Premium Member Only 17.92 18.27 18.67 17.14 14.11

WDB coco Co Semi-Annual Data
Mar18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.03 17.71 16.60 11.56 16.66

TSE:7079 vs VEEV, BTSG, TEM: Net Margin % Comparison

For the Health Information Services subindustry, WDB coco Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


WDB coco Co Net Margin % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, WDB coco Co's Net Margin % distribution charts can be found below:

* The bar in red indicates where WDB coco Co's Net Margin % falls into.


TSE:7079
78GF Score
WDB coco Co Ltd TSE:7079
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

WDB coco Co Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

WDB coco Co's Net Margin for the fiscal year that ended in Mar. 2026 is calculated as

Net Margin=Net Income (A: Mar. 2026 )/Revenue (A: Mar. 2026 )
=679.306/4815.813
=14.11 %

WDB coco Co's Net Margin for the quarter that ended in Mar. 2026 is calculated as

Net Margin=Net Income (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=400.191/2401.467
=16.66 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 16.66% mean?
WDB coco Co (TSE:7079) has a Net Margin % of 16.66% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on WDB coco Co and its competitors. This is 15% above median its historical median of 14.52. Over the past decade, WDB coco Co's Net Margin % has ranged from 13.28 to 18.67. According to the industry distribution chart, WDB coco Co ranks #89 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 13.3%.
Is WDB coco Co's Net Margin % too high?
WDB coco Co's current Net Margin % of 16.66% is 15% above median its 10-year median of 14.52. Over the past 10 years, this metric has ranged from a low of 13.28 to a high of 18.67. The Healthcare Providers & Services industry median Net Margin % is 2.89. WDB coco Co's value of 16.66% is 477.5% above this industry median. Based on the distribution chart, WDB coco Co ranks #89 out of 668 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, WDB coco Co has a GF Score™ of 78/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does WDB coco Co's Net Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, WDB coco Co ranks #89 out of 668 companies for Net Margin %. This places WDB coco Co in the top 13% of its industry — outperforming the majority of peers. The industry median Net Margin % is 2.89. WDB coco Co's value of 16.66% is 477.5% above this benchmark. Historically, WDB coco Co's own Net Margin % has ranged from 13.28 to 18.67 over the past decade. While the company's 10-year median is 14.52 vs. the industry median of 2.89, WDB coco Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Healthcare Providers & Services company?
The median Net Margin % among Healthcare Providers & Services companies is 2.89, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. WDB coco Co's current Net Margin % of 16.66% is 477.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on WDB coco Co and its competitors. For the Healthcare Providers & Services industry, the median Net Margin % is 2.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. WDB coco Co's current Net Margin % is 16.66%, which is 15% above median its own 10-year median of 14.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is WDB coco Co stock overvalued right now?
Based on GuruFocus' analysis, WDB coco Co (TSE:7079) is currently considered Modestly Undervalued. The stock's GF Value™ is 円3,452.59, compared to a current price of 円2,529.00 — trading 26.8% below its estimated fair value. The current Net Margin % is 16.66%, which is 15% above median its 10-year median of 14.52 and 477.5% above the Healthcare Providers & Services industry median of 2.89. WDB coco Co's overall GF Score™ is 78/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For WDB coco Co (TSE:7079), the current Net Margin % is 16.66% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is WDB coco Co (TSE:7079) Overvalued in 2026?

Based on GuruFocus' analysis, WDB coco Co stock appears to be undervalued. The current stock price of 円2,529.00 is trading 26.8% below its estimated GF Value™ of 円3,452.59. GuruFocus considers WDB coco Co to be Modestly Undervalued.

Key valuation signals for TSE:7079:

  • Net Margin %: 16.66% (15% above median its 10-year median of 14.52)
  • GF Value™: 円3,452.59 vs. price of 円2,529.00 (26.8% below fair value)
  • GF Score™: 78/100 with 3 warning signs
  • Industry Position: 477.5% above the Healthcare Providers & Services median (#89 of 668)

No single metric tells the full story. See the TSE:7079 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


WDB coco Co Business Description

Address 1-8-11 Harumi, Chuo-ku, Triton Square Y Building, 27th Floor, Tokyo, JPN, 104-6127
WDB coco Co Ltd is a provider of safety information management for the development of pharmaceuticals and medical devices. Its services include business related to safety information management, preparation of materials related to regulatory application, QC-related work, PMS facility contract support related work, clinical research support/monitoring, and temporary staffing. The company provides Contract Research Organization services for all new drug developments, such as monitoring, safety information, data management, and statistical analysis. It provides support for the development of generic drugs, such as bioequivalence studies and biosimilars, clinical research, and physician-led clinical trials.
78GF Score

Get the complete analysis for TSE:7079

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円2,529.00
Price
円3,452.59
GF Value